1. 1.Huang, Y.#,Lu, C.#, Wang, H., ... & Li, G. M. (2023). DNAJA2 deficiency activates cGAS-STING pathway via the induction of aberrant mitosis and chromosome instability.Nature Communications,14(1):5246.

2. Cai, Y., Zhang, A.,Lu, C.*. (2022). Precision intervention of cell type-specific targeting is required for future cancer immunotherapy.Medical Review, 2(6), 553-554.

3.Lu, C.#, Guan, J.#, Lu, S., Jin, Q., Rousseau, B., Lu, T., ... & Fu, Y. X. (2021). DNA sensing in mismatch repair-deficient tumor cells is essential for anti-tumor immunity.Cancer Cell, 39(1), 96-108.

This paper is previewed byCancer Cell(https://www.cell.com/cancer-cell/fulltext/S1535-6108(20)30664-4); Elected as EACR’s Top 10 Cancer Research Publications in 2020; A highly cited paper in Web of Science.

4. Guan, J.#,Lu, C.#, Jin, Q., Lu, H., Chen, X., Tian, L., ... & Li, G. M. (2021). MLH1 deficiency-triggered DNA hyperexcision by exonuclease 1 activates the cGAS-STING pathway.Cancer Cell, 39(1), 109-121. A highly cited paper in Web of Science.

5. Liu, L., Chen, J., Zhang, H., Ye, J., Moore, C.,Lu, C., Fang, Y., Fu, Y. X., & Li, B. (2022). Concurrent delivery of immune checkpoint blockade modulates T cell dynamics to enhance neoantigen vaccine-generated antitumor immunity.Nature cancer, 3(4), 437–452.

6. Zhang, A., Ren, Z., Tseng, K. F., Liu, X., Li, H.,Lu, C., Cai, Y., Minna, J. D., & Fu, Y. X. (2021). Dual targeting of CTLA-4 and CD47 on T_regcells promotes immunity against solid tumors.Science translational medicine,13(605), eabg8693.

7. Li, H. D.,Lu, C., Zhang, H., Hu, Q., Zhang, J., Cuevas, I. C., Sahoo, S. S., Aguilar, M., Maurais, E. G., Zhang, S., Wang, X., Akbay, E. A., Li, G. M., Li, B., Koduru, P., Ly, P., Fu, Y. X., & Castrillon, D. H. (2020). A PoleP286R mouse model of endometrial cancer recapitulates high mutational burden and immunotherapy response.JCI insight,5(14), e138829.

8. Han, C., Liu, Z., Zhang, Y., Shen, A., Dong, C., Zhang, A., Moore, C., Ren, Z.,Lu, C., Cao, X., Zhang, C. L., Qiao, J., & Fu, Y. X. (2020). Tumor cells suppress radiation-induced immunity by hijacking caspase 9 signaling.Nature immunology,21(5), 546–554.

9. Suresh, S., Chen, B., Zhu, J., Golden, R. J.,Lu, C., Evers, B. M., Novaresi, N., Smith, B., Zhan, X., Schmid, V., Jun, S., Karacz, C. M., Peyton, M., Zhong, L., Wen, Z., Sathe, A. A., Xing, C., Behrens, C., Wistuba, I. I., Xiao, G., … O'Donnell, K. A. (2020). eIF5B drives integrated stress response-dependent translation of PD-L1 in lung cancer.Nature cancer,1(5), 533–545.

10. Liu, Z., Han, C., Dong, C., Shen, A., Hsu, E., Ren, Z.,Lu, C., Liu, L., Zhang, A., Timmerman, C., Pu, Y., Wang, Y., Chen, M., Qiao, J., & Fu, Y. X. (2019). Hypofractionated EGFR tyrosine kinase inhibitor limits tumor relapse through triggering innate and adaptive immunity.Science immunology,4(38), eaav6473.

11. Li, H. D., Cuevas, I., Zhang, M.,Lu, C., Alam, M. M., Fu, Y. X., You, M. J., Akbay, E. A., Zhang, H., & Castrillon, D. H. (2018). Polymerase-mediated ultramutagenesis in mice produces diverse cancers with high mutational load.The Journal of clinical investigation, 128(9), 4179–4191.